Race Pacing Science for HYROX: Mid‑Race Fade, Transition Cost, and Where Athletes Lose Time
Executive summary
HYROX pacing is not just “8 × 1 km at a steady pace.” It is repeated re‑establishment of runnable economy and controllable physiology immediately after high-force, high-lactate functional work, with minimal opportunity for full recovery. The practical result is a recurring transition cost (time + physiology) that accumulates and often manifests as mid‑to‑late race run-split fade (positive pacing) and/or technical breakdown on late stations. [1]
The peer‑reviewed HYROX evidence base is still small. The first scientific simulated HYROX competition study (11 recreational athletes) provides strong quantitative anchors: median total time 86.5 min, with 51.2 min running and 32.8 min stations, meaning running is the dominant time component (~59% of total). Exercise stations produced higher peak lactate and exertion than runs, and the highest HR, blood lactate, and RPE occurred at wall balls (the final station). Faster total performance correlated strongly with higher VO₂max and higher endurance training volume, and correlations were present for running time but not station time—supporting the interpretation that pacing control of repeated runs is a primary determinant of overall outcome. [2]
Transition cost has two “coupled” components that coaches must treat separately:
- Mechanical/time cost (Roxzone): HYROX courses explicitly combine run course, Roxzone, and station distances; running splits are “around 1,000 m” and vary by venue layout, meaning extra distance/time is structurally embedded in transitions. [3]
- Physiological cost: runs begin “hot” (elevated HR, ventilation, metabolites), and re‑stabilizing below critical thresholds is harder after stations, accelerating fatigue‑driven decoupling and pacing collapse. [4]
Because running accounts for ~59% of total time in the published HYROX simulation, small decrements in average run speed create large finish‑time penalties (e.g., a 3% slowdown in aggregate run time plausibly adds ~1.5–1.6 minutes to an ~86.5 min race, holding stations constant). [5]
Evidence base and evidence-weighting note
What is known from peer‑reviewed HYROX data
The single peer‑reviewed simulated HYROX study provides the best available “ground truth” for pacing discussions:
- Time structure: runs took longer than stations (median 51.2 vs 32.8 min). [6]
- Intensity structure: most time was spent at hard/very hard intensities by %HRmax, with stations eliciting higher lactate and RPE than runs. [5]
- Peak stress point: the largest HR/lactate/RPE values occurred at wall balls (final station), consistent with late-race failure patterns. [7]
- Performance determinants: VO₂max and endurance training volume correlated with overall and running performance, not station performance (in that sample). [8]
A scoping review of high‑intensity functional training (HIFT) in hybrid competitions reinforces that HYROX is a standardized hybrid format and recapitulates the finding that wall balls were most demanding in the simulated HYROX study, while also emphasizing mixed‑modality fatigue and the importance of sequencing/training design. [9]
What is not yet established empirically in peer-reviewed HYROX science
HYROX‑specific scientific evidence remains limited or absent for:
- Station‑by‑station causal effects on the subsequent 1 km run split (i.e., which station produces the largest next-run penalty, quantified). The simulation reports physiology after each run/station but does not (in the accessible figures/tables) provide an analysis of station → next run time penalty as the primary outcome. [10]
- Large‑scale observational analyses of official race split data published in peer‑reviewed outlets.
Therefore, for “where athletes lose time,” this review combines: (i) the limited HYROX peer‑reviewed base, (ii) official rulebook constraints on course geometry and transitions, and (iii) high‑confidence general pacing/fatigue physiology from endurance and hybrid sports.
Evidence weighting for key HYROX pacing claims
| Claim | Evidence strength | Rationale / primary sources |
| Running is the dominant time component (and therefore a high-leverage pacing target) | Strong (HYROX-specific) | Simulation quantified run vs station time. [5] |
| Stations impose higher internal load (lactate, RPE) than runs, driving “hot starts” into runs | Strong (HYROX-specific) | Higher BLmax and RPEmax during stations vs runs; segment physiology shown. [11] |
| Wall balls are the maximal stress point and a frequent late-race failure locus | Strong (HYROX-specific) | Peak HR/BL/RPE at wall balls in simulation; reiterated in hybrid literature. [12] |
| Specific stations (e.g., sled pull, burpee broad jumps, lunges) uniquely cause the largest next-run pace penalty | Absent/Limited (HYROX-specific) | Plausible mechanistic ranking exists, but direct peer‑reviewed station→run penalty quantification is not established. [13] |
| Pacing collapse tends to occur mid‑to‑late race (positive pacing) | Moderate (general); Limited (HYROX-specific) | Positive pacing is common in prolonged events; HYROX-specific split sequencing data are not yet peer‑review established. [14] |
| Transition time (Roxzone) is a meaningful time-loss category and is structurally embedded | Strong (rules); Limited (quantification) | Rulebook defines Roxzone and combined course distances; magnitude varies by venue and athlete. [3] |
Where athletes lose time in HYROX: runs, stations, and transitions
Time-loss anatomy: a decomposition approach
A useful analytic decomposition is:
Finish time = Σ(run splits) + Σ(station times) + Σ(transition/Roxzone time) + penalties
The simulation study explicitly reports totals for run time and station time. The remaining “unassigned” time (total minus runs minus stations) can be treated as the combined remainder (e.g., transitions, brief delays, measurement artifacts). Using their medians: 86.5 − 51.2 − 32.8 = 2.5 min (≈2.9% of total). This is a conservative estimate because lab simulations likely under‑represent venue Roxzone distances and crowding. [5]
The official rulebook clarifies why Roxzone can be nontrivial: HYROX courses combine run course, Roxzone, and station distances; splits around 1,000 m may require multiple laps depending on venue. This implies both (a) extra distance and (b) navigation/positioning costs in every transition. [3]
Mid-race pace fade: what “pacing collapse” looks like in HYROX terms
Even without large HYROX split datasets in peer‑reviewed literature, pacing science strongly predicts that repeated high internal load with incomplete recovery promotes positive pacing (progressive slowing after an early peak), especially when athletes start too aggressively. [14]
HYROX adds two pacing-specific amplifiers:
- Compounded transitions: each run starts under residual fatigue and elevated ventilation/HR. [15]
- Late‑race station severity: wall balls appear as the physiological high point in the one peer‑reviewed HYROX simulation; this is consistent with “late bottleneck” behavior in many hybrid events where final tasks combine local muscular endurance, coordination under fatigue, and high ventilatory drive. [12]
Which stations most impair subsequent running?
Peer‑reviewed answer (strict): We do not yet have published HYROX data that quantifies, station‑by‑station, the causal decrement in subsequent 1 km run speed as the primary outcome.
Best-supported proxy approach today: infer likely transition impact from station-induced internal load (lactate, HR, RPE) plus known modality-specific fatigue mechanisms.
In the simulation, stations were generally associated with higher lactate and RPE than runs, and segment-by-segment physiology shows sustained high lactate with a pronounced late spike at wall balls. [11]
This supports the mechanism that stations “reset” the internal load upward, so the next run begins closer to severe-domain instability (critical speed/power framing), increasing the likelihood of early overshoot and later fade. [16]
Mechanistic pathways linking stations to pacing collapse
HYROX pacing collapse can be modeled as an interaction of (i) metabolic disturbance, (ii) neuromuscular performance fatigability, (iii) cardiovascular/respiratory constraints, (iv) thermoregulation, and (v) perception/central regulation.
Mechanisms table: pathways vs acute effects on pacing
| Pathway | Core mechanism | What it does to pacing/run economy after a station | Evidence base (general vs HYROX-specific) |
| Metabolic: lactate + acid–base disturbance | Lactate reflects high glycolytic flux; lactate itself does not cause acidosis; ATP hydrolysis and ionic shifts drive fatigue-relevant disturbance | Higher “cost” for a given pace; reduced ability to stabilize; greater risk of early-run overshoot leading to later fade | Strong general (lactate/acidosis biochemistry); Moderate HYROX (high lactate throughout) [17] |
| Metabolic: PCr depletion | PCr resynthesis is oxygen- and blood-flow-dependent; biphasic recovery; occlusion abolishes PCr resynthesis | Reduces acceleration capacity; “flat legs” early in run; increases reliance on glycolysis for surges | Strong general [18] |
| Neuromuscular: peripheral fatigue | Metabolite accumulation and excitation–contraction coupling changes reduce force and efficiency | Increases ground contact time, reduces stiffness; worsens running economy; increased variability and pacing instability | Strong general; Moderate HYROX by inference [19] |
| Neuromuscular: EIMD (damage component) | Eccentric-biased or unaccustomed work can impair force and reduce economy for hours–days | Post-race and post-simulation “durability” degraded; mid/late pace fade more pronounced in damage-prone athletes; injury risk rises with fatigue | Moderate general; HYROX-specific quantification limited [20] |
| Cardiovascular: HR elevation and drift | Prolonged work raises HR and can reduce stroke volume after ~10–20 min; drift is amplified by heat/dehydration | Higher HR for the same pace; “ceiling” reached sooner; decoupling (internal/external ratio worsens) mid‑race | Strong general [21] |
| Respiratory: work of breathing | Respiratory muscle work can limit limb blood flow via metaboreflex; high ventilation is costly | After stations that spike ventilation, running feels disproportionately hard; early-run dyspnea drives conservative pacing | Strong general [22] |
| Thermoregulation | Indoor heat storage + repeated bursts increase skin blood flow demands and cardiovascular strain | Earlier HR drift and pace fade; more transition walking and “unplanned” recovery | Moderate general [23] |
| Central/perceptual regulation | Pacing governed by feedforward/feedback, motivation, and perception of effort; hyperammonemia may affect brain function during extreme exercise | Aggressive early pacing becomes “unsustainable” perception-wise; later motivation collapse; tactical errors in transitions | Moderate general (models + ammonia literature) [24] |
Time-course of transition cost versus mid-race fade
A useful distinction for coaches:
- Fast processes (seconds–minutes): PCr resynthesis, ventilation normalization, acute metabolite effects → these dominate immediate post-station running. [25]
- Slow processes (tens of minutes–hours): cardiovascular drift + heat storage and progressive substrate depletion → these dominate mid-to-late race fade. [26]
- Delayed processes (hours–days): EIMD and associated neuromuscular impairment → these dominate recovery and injury risk rather than in-race splits (unless damage is severe or technique is poor). [20]
Conceptual visualization: trajectories pre- vs post-station and mid-race fade
Conceptual patterns (same athlete)
A) Fresh 1 km
Pace: ─────────────── (stable)
HR: ───╱────────── (ramps then steadies)
Lactate:╱───────────── (small rise then stable)
Power: ─────────────── (stable external output)
B) 1 km immediately after a hard station
Pace: ───╲────╲───── (early overshoot risk → fade)
HR: ─────────────╱ (starts high, drifts higher)
Lactate:────╱───────── (already high; may rise further)
Power: ───╲────╲───── (external output decays at same RPE)
C) Mid-race fade across repeated segments
Run split times: R1 < R2 ≈ R3 < R4 < R5 < R6 < R7 < R8 (typical “positive pacing” if unmanaged)
These visual patterns align with (i) sustained high lactate/HR observed in the HYROX simulation and (ii) established pacing science describing positive pacing in prolonged events. [27]
Biomarkers, monitoring, and testing to quantify pacing fade and transition cost
Table: monitoring tools—pros/cons and decision thresholds
| Metric / tool | What it indicates | Strengths | Key limitations | Practical decision thresholds (examples, not universal) |
| Blood lactate (spot after stations/runs) | Internal metabolic strain; lactate kinetics across race | Direct internal load; can identify “station spikes” | Sampling burden; lactate is not the cause of acidosis; inter-individual variability | If lactate after a mid-race station is consistently “high” and next-run pace collapses, pacing/technique intervention is higher priority than more fitness work [28] |
| HR and HR drift | Cardiovascular strain; heat/hydration effects; durability | Low cost, continuous | HR lag; affected by heat, caffeine, stress | Marked drift at steady external load suggests durability limitations; for HYROX, rising HR across runs at stable pace flags accumulating stress [21] |
| Internal-to-external decoupling (HR vs speed/run power) | “Durability” and onset of inefficiency | Quantifies “pace cost” changes; supports segment by segment analysis | Requires stable measurement; terrain/venue affects speed | Large or early decoupling onset predicts worse endurance performance in large datasets; HYROX analog: early decoupling across run legs may indicate transition vulnerability [29] |
| Running power (and power–HR ratio) | External workload stability and pacing control | Less sensitive to terrain indoors; pairs well with HR for decoupling | Device- and model-dependent; needs athlete calibration | If post-station run power drops at equal RPE, focus on station pacing and transition drills (not just “run faster”) [30] |
| Wearable NIRS (muscle oxygenation) | Local O₂ delivery/utilization and “local limitation” | Real-time local insight; growing evidence base | Device placement variability; interpretation is nontrivial | If SmO₂ fails to recover in Roxzone and next-run pace drops, suspect local perfusion/respiratory-metaboreflex constraints [31] |
| CK (creatine kinase) | Muscle damage load (EIMD proxy) | Useful in heavy eccentric/volume blocks | Very large inter-individual variability; delayed peak | If CK trends up week-to-week with deteriorating run economy and soreness, de-load and reduce damage-heavy station volumes [32] |
| Ammonia (research/elite monitoring) | Potential CNS stress during extreme exercise | Mechanistically relevant in severe fatigue | Limited field access | Consider during maximal-intensity blocks; interpret with caution; mainly research-grade tool [33] |
| HRV (daily) | Autonomic recovery state | Scalable readiness indicator | Needs strict measurement protocol; relationship to performance is context-dependent | Persistent HRV suppression + rising session RPE → reduce VO₂/high-density simulation; rebuild with lower density and better recovery [34] |
Table: testing protocols to quantify transition cost and pacing resilience
| Protocol | What it isolates | Outputs | Interpretation for HYROX pacing |
| Station → 1 km test (single transition) | Acute transition cost from a specific station | Δ1 km time vs fresh; HR/lactate/RPE; run-power decoupling | Quantifies which station(s) produce biggest next-run penalty for that athlete (even if population data are lacking) |
| Mini‑HYROX simulation (reduced volume) | Repeated transitions and mid-race fade | Run split slope (R1→R8), station time drift, Roxzone time | Best ecological validity; identifies whether fade is metabolic, technical, or tactical [35] |
| Critical speed/power modeling + fatigue condition | The boundary between stabilizable and non-stabilizable intensities | CS/CP and D′/W′; shift after station block | If next-run pace sits above CS after stations, severe-domain instability drives progressive fade [36] |
| Neuromuscular battery around stations | Peripheral fatigue and coordination cost | CMJ decrement, isometric force/RFD changes | CMJ is widely used for neuromuscular fatigue monitoring; decrements suggest the legs cannot maintain stiffness/economy in the next run [37] |
| Running biomechanics under fatigue (wearables/lab) | Mechanism of economy loss and injury risk | Contact time, stiffness proxies, asymmetry | Fatigue induces injury-relevant mechanical changes; monitor when adding high-density simulations [38] |
Finish-time sensitivity and pacing models for HYROX
Sensitivity analysis using run share
Using the peer‑reviewed simulation medians: run time ~51.2 min of 86.5 min total ⇒ run share ≈ 0.59. [6]
A simple first‑order sensitivity (holding stations and Roxzone constant):
ΔT_total ≈ 0.59 × ΔT_run
Assuming a baseline total time T and run share 0.59, a percentage run slowdown p yields approximately ΔT_total ≈ T × 0.59 × p.
Sensitivity table: plausible run-split decrements → finish-time penalty
| Baseline finish time (example) | 1% slower aggregate run time | 3% slower | 5% slower | 8% slower |
| 70:00 | +0:25 | +1:14 | +2:04 | +3:18 |
| 86:30 (close to simulation median) | +0:31 | +1:32 | +2:34 | +4:05 |
| 100:00 | +0:35 | +1:46 | +2:57 | +4:43 |
This table uses the simulation-derived run share (~0.59) as a conservative anchor; actual run share can differ by athlete level, division, and venue geometry. [39]
Transition (Roxzone) time-loss modeling
The rulebook implies that Roxzone is structurally embedded in the course and that venue layout impacts split structure. [3]
Therefore, a practical model is:
T_total = T_run + T_station + T_roxzone + penalties
Even small Roxzone savings (e.g., 30–90 seconds total) can be performance-relevant, especially because they are often “free speed” (organization and route choice) rather than fitness-limited. The best peer-reviewed quantification of Roxzone share is currently limited, but the existence and variability of Roxzone elements are strongly supported by official rulebook architecture. [3]
Practical coaching implications for pacing, transition resilience, and risk management
Core pacing principles translated to HYROX
General pacing science indicates that for prolonged events, performance is usually improved by avoiding “explosive all‑out” starts and distributing effort more evenly; positive pacing (progressive slowing) is common when early intensity is too high. [14]
HYROX amplifies the penalty of early overshoot because every run begins after a metabolic/ventilatory disruption, pushing athletes closer to severe-domain instability (critical speed framing). [40]
Evidence from hybrid-format analogs supports the practical value of restraint: - In triathlon, a swim intensity below time-trial effort improved subsequent cycling and overall performance, demonstrating that early discipline can protect downstream performance. [41]
- In a CrossFit workout (Fight Gone Bad), controlled-split pacing outperformed all-out pacing, supporting the general principle that early overexertion degrades later output in mixed-modality tasks. [42]
Table: session templates to train transition resilience
| Session template | What it trains | Example structure (illustrative; weekly hours unspecified) | Primary monitoring |
| Station‑primed controlled 1 km repeats | “Hot start” pacing discipline | (Station at controlled intensity) → 1 km @ target pace; repeat 4–6× | Run split stability; HR drift across reps; lactate spot-check optionally [43] |
| Over‑under run segments with station inserts | Severe-domain avoidance and re-stabilization | 400 m slightly fast + 600 m controlled, immediately after station; repeat | Running power/pace decoupling; RPE calibration [44] |
| Roxzone rehearsal + “micro-reset” | Transition time + physiological reset | Practice entry/exit lines, equipment setup, breathing reset; keep moving | Total Roxzone time; HR recovery slope [3] |
| Split-pacing station strategy | Prevent station-induced runaway fatigue | First half of station controlled, second half push (avoid early spike) | Station time consistency; lactate/RPE pattern [45] |
| Neuromuscular durability block | Preserve mechanics under fatigue | Strength-endurance station + short run; then CMJ test pre/post | CMJ delta and asymmetry; athlete-reported stiffness [46] |
| Heat/ventilation management simulation | Reduce drift-driven collapse | Indoor simulation with controlled cooling/hydration practices | HR drift; perceived thermal strain [26] |
Periodization/decision flowchart for coaches
This decision process is anchored to: (i) HYROX structural requirements in the rulebook, (ii) CP/CS domain logic, and (iii) pacing science pointing to the cost of early overshoot and the value of controlled splits. [47]
Injury risk and pacing strategies: why “fade” is not just performance-relevant
A growing body of evidence shows fatigue produces systematic changes in running mechanics (e.g., increased ground contact time, reduced ankle power/stiffness), which may preserve short-term performance but can also create injury-relevant loading conditions. [48]
Thus, athletes who repeatedly pace above sustainable limits and then “survive” by altering mechanics may not only lose time but also increase injury susceptibility. Training plans should include fatigue-aware technique work and progressive exposure to race-like density rather than frequent maximal simulations. [49]
Sex, athlete level, and training history: who is most at risk of pacing collapse?
HYROX-specific sex-stratified pacing evidence is currently limited in peer‑reviewed literature. However, sex differences in performance fatigability are well established as task-dependent: women are often less fatigable in some isometric and certain dynamic tasks, but differences vary by contraction type, velocity, and muscle group. This matters in HYROX because stations vary widely in contraction demands (sleds, carries, repeated squats, ergometry). [50]
Athlete history shapes pacing collapse through: - Eccentric tolerance and repeated bout effect: damage susceptibility changes over time, influencing whether late-race economy loss is dominated by acute metabolite fatigue vs damage-related inefficiency. [51]
- Aerobic durability: athletes with better durability show less internal-to-external decoupling and later onset of performance loss. Large datasets demonstrate decoupling predicts endurance outcomes, suggesting value for HYROX analog monitoring across repeated run segments. [52]
In‑race tactics, recovery, and nutrition rules
The official HYROX rulebook states that water is made available at least once during/before/after each pass through the Roxzone and that athletes must carry any desired nutrition from the start; accepting outside assistance carries penalties. This makes Roxzone not only a transition zone but also the practical locus for planned hydration and micro-recovery behaviors. [53]
Active recovery can, in some contexts, enhance lactate removal versus passive recovery, but evidence is protocol-dependent and not uniformly positive; therefore, “move through Roxzone” should be implemented as low-cost movement rather than adding extra intensity that worsens ventilation and drift. [54]
Research gaps, prioritized study designs, and critical questions for coaches
Priority research gaps
- Station→next-run penalty mapping: quantify which station(s) impose the largest immediate decrement in the subsequent 1 km, controlling for pacing strategy and athlete level. Current HYROX physiology data do not yet establish this outcome as a quantified primary endpoint. [10]
- Pacing phenotype taxonomy: identify whether HYROX athletes fail by (a) metabolic overshoot, (b) neuromuscular collapse, (c) drift/heat, or (d) technical/psychological disruption—and which interventions correct each phenotype. [55]
- Validated monitoring thresholds in hybrid contexts: how best to interpret HRV, NIRS, and decoupling across repeated transitions rather than continuous endurance exercise. [56]
- Sex-stratified and level-stratified HYROX pacing datasets: given task-specific fatigability differences, HYROX needs sex-aware station mapping and pacing guidance. [50]
Recommended study designs
- Crossover lab simulation: standardized station (or station pair) → standardized 1 km run; repeat across stations; outcomes include run split decrement, VO₂/ventilation, lactate kinetics, and biomechanics. [25]
- RCT across pacing strategies: controlled-split vs aggressive early pacing in HYROX simulation format, building on mixed-modality pacing evidence (CrossFit and triathlon analogs) to test pacing-causality. [57]
- Longitudinal intervention (8–12 weeks): training blocks targeting (i) aerobic durability/decoupling reduction, (ii) station technique/pacing, or (iii) transition rehearsal; evaluate changes in transition cost and run-split slope. [58]
- Mechanistic NIRS + CP/CS studies: quantify whether station-induced hypoperfusion or respiratory-metaboreflex markers predict next-run speed loss, and how CP/CS “effective boundary” shifts after stations. [59]
Critical reflective questions for coaches
- If your athlete fades, can you separate time loss into (a) run split slope, (b) station time drift, and (c) Roxzone time? Which component is dominant? [39]
- Does the athlete’s run pace after stations sit above their CS/CP (severe-domain) more often than they realize—forcing unavoidable late-race collapse? [36]
- Are late-race failures driven by metabolic overshoot (lactate/ventilation spike) or neuromuscular collapse (CMJ decrement, stiffness loss)—and are you training the correct limiter? [60]
- Do your simulations reproduce the venue-specific Roxzone constraints (distance, routing, decision load), or are you underestimating transition cost? [3]
- Are you managing fatigue-related injury risk by progressively exposing athletes to race density, given evidence that fatigue changes running mechanics in injury-relevant ways? [49]
References
- HYROX-specific primary sources
- Brandt T, et al. Acute physiological responses and performance determinants in HYROX© – a running-focused high intensity functional fitness trend. Frontiers in Physiology (2025). PMID: 40230601; PMCID: PMC11994925. [61]
- HYROX Rulebook Singles (Season 25/26). Official rulebook sections on Roxzone, run structure, and hydration/nutrition rules. [53]
- Villarroel López PV, et al. High-Intensity Functional Training in Hybrid Competitions: A Scoping Review of Performance Models and Physiological Adaptations. (2025). PMCID: PMC12550923. [9]
- Core pacing and domain theory
- Abbiss CR, Laursen PB. Describing and understanding pacing strategies during athletic competition. Sports Medicine (2008). PMID: 18278984. [14]
- Poole DC, et al. Critical Power: An Important Fatigue Threshold in Exercise Physiology. Med Sci Sports Exerc (2016). DOI: 10.1249/MSS.0000000000000939. PMCID: PMC5070974. [62]
- Mechanistic physiology used for HYROX translation
- Robergs RA, et al. Biochemistry of exercise-induced metabolic acidosis. Am J Physiol Regul Integr Comp Physiol (2004). PMID: 15308499. [63]
- Harris RC, et al. The time course of phosphorylcreatine resynthesis during recovery… Pflügers Archiv (1976). PMID: 1034909. DOI: 10.1007/BF00585149. [64]
- Allen DG, et al. Skeletal muscle fatigue: cellular mechanisms. Physiol Rev (2008). PMID: 18195089. [65]
- Coyle EF. Cardiovascular drift during prolonged exercise: new perspectives. Exerc Sport Sci Rev (2001). PMID: 11337829. [21]
- Dempsey JA, et al. Consequences of exercise-induced respiratory muscle work. Respir Physiol Neurobiol (2006). [66]
- Monitoring and fatigue/injury context
- Smyth B, et al. Decoupling of Internal and External Workload During a Marathon… (2022). PMCID: PMC9388405. [52]
- Plews DJ, et al. Training adaptation and heart rate variability in elite endurance athletes. (2013). PMID: 23852425. [34]
- Baird MF, et al. Creatine-Kinase- and Exercise-Related Muscle Damage… (2012). PMCID: PMC3263635. [67]
- Choudhary PK, et al. Lower-Limb Biomechanical Adaptations to Exercise-Induced Fatigue During Running: A Systematic Review of Injury-Relevant Mechanical Changes. (2026). PMID: 41752909; PMCID: PMC12942261. [48]
- Hunter SK. The relevance of sex differences in performance fatigability. (2016). PMCID: PMC5349856. [68]
- Transition and pacing analogs (to inform HYROX hypotheses)
- Peeling PD, et al. Effect of swimming intensity on subsequent cycling and overall triathlon performance. Br J Sports Med (2005). DOI: 10.1136/bjsm.2005.020370. PMID: 16306507. [41]
- Ribeiro G, et al. Fatigue and performance rates as decision-making criteria in pacing control during CrossFit®. (2024). PMID: 38635574. [42]
[1] [2] [4] [5] [6] [8] [10] [11] [13] [35] [39] [61] Acute physiological responses and performance determinants in Hyrox© – a new running-focused high intensity functional fitness trend - PMC
https://pmc.ncbi.nlm.nih.gov/articles/PMC11994925/
[3] [47] https://maintain.hyrox.com/rulebooks/HYROX_RulebookSingles_EN.pdf
https://maintain.hyrox.com/rulebooks/HYROX_RulebookSingles_EN.pdf
[7] [12] [15] [27] [60] cdn.ncbi.nlm.nih.gov
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/348d/11994925/25b3380c8e81/fphys-16-1519240-g005.jpg
[9] https://pmc.ncbi.nlm.nih.gov/articles/PMC12550923/
https://pmc.ncbi.nlm.nih.gov/articles/PMC12550923/
[14] [24] https://pubmed.ncbi.nlm.nih.gov/18278984/
https://pubmed.ncbi.nlm.nih.gov/18278984/
[16] [36] [40] [44] [55] [62] https://pmc.ncbi.nlm.nih.gov/articles/PMC5070974/
https://pmc.ncbi.nlm.nih.gov/articles/PMC5070974/
[17] [28] [63] https://pubmed.ncbi.nlm.nih.gov/15308499/
https://pubmed.ncbi.nlm.nih.gov/15308499/
[18] [25] [64] https://pubmed.ncbi.nlm.nih.gov/1034909/
https://pubmed.ncbi.nlm.nih.gov/1034909/
[19] [65] https://pubmed.ncbi.nlm.nih.gov/18195089/
https://pubmed.ncbi.nlm.nih.gov/18195089/
[20] [51] https://pmc.ncbi.nlm.nih.gov/articles/PMC3575608/
https://pmc.ncbi.nlm.nih.gov/articles/PMC3575608/
[21] [26] [43] https://pubmed.ncbi.nlm.nih.gov/11337829/
https://pubmed.ncbi.nlm.nih.gov/11337829/
[22] [66] https://www.sciencedirect.com/science/article/abs/pii/S1569904806001091
https://www.sciencedirect.com/science/article/abs/pii/S1569904806001091
[23] https://pubmed.ncbi.nlm.nih.gov/9694416/
https://pubmed.ncbi.nlm.nih.gov/9694416/
[29] [30] [52] [58] https://pmc.ncbi.nlm.nih.gov/articles/PMC9388405/
https://pmc.ncbi.nlm.nih.gov/articles/PMC9388405/
[31] [59] https://pmc.ncbi.nlm.nih.gov/articles/PMC12869849/
https://pmc.ncbi.nlm.nih.gov/articles/PMC12869849/
[32] [67] https://pmc.ncbi.nlm.nih.gov/articles/PMC3263635/
https://pmc.ncbi.nlm.nih.gov/articles/PMC3263635/
[33] https://pubmed.ncbi.nlm.nih.gov/20138956/
https://pubmed.ncbi.nlm.nih.gov/20138956/
[34] [56] https://pubmed.ncbi.nlm.nih.gov/23852425/
https://pubmed.ncbi.nlm.nih.gov/23852425/
[37] [46] https://www.sciencedirect.com/science/article/abs/pii/S1440244016301542
https://www.sciencedirect.com/science/article/abs/pii/S1440244016301542
[38] https://pmc.ncbi.nlm.nih.gov/articles/PMC12942261/
https://pmc.ncbi.nlm.nih.gov/articles/PMC12942261/
[41] https://pubmed.ncbi.nlm.nih.gov/16306507/
https://pubmed.ncbi.nlm.nih.gov/16306507/
[42] [45] [57] https://pubmed.ncbi.nlm.nih.gov/38635574/
https://pubmed.ncbi.nlm.nih.gov/38635574/
[48] [49] https://pubmed.ncbi.nlm.nih.gov/41752909/
https://pubmed.ncbi.nlm.nih.gov/41752909/
[50] [68] https://pmc.ncbi.nlm.nih.gov/articles/PMC5349856/
https://pmc.ncbi.nlm.nih.gov/articles/PMC5349856/
[53] https://hyrox.com/wp-content/uploads/2025/07/25_26_HYROX_RulebookSingles_EN.pdf
https://hyrox.com/wp-content/uploads/2025/07/25_26_HYROX_RulebookSingles_EN.pdf
[54] https://journals.lww.com/nsca-jscr/fulltext/2019/08000/a_systematic_review_on_the_effectiveness_of_active.26.aspx